Andy Hartman

Andy Hartman is the Director of Corporate Quality and Compliance at Horizon Therapeutics and his group is specifically focused on oversight of Horizon’s clinical development and LCM development products/projects. Andy has held roles of increasing responsibility in sponsor organizations in Quality Control, Regulatory CMC, and Quality Assurance. His experiences have included work on pre-clinical candidates, product launches, products marketed for greater than 30 years, and everything in between.